Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Prenetics of Hong Kong Raises $10 Million for Pharmacogenomics Test

publication date: Mar 16, 2016
Prenetics, a Hong Kong DNA biotechnology firm, raised $10 million in a Series A funding led by China's Ping An Ventures. Prenetics is developing the iGenes test that makes pharmacogenomics available in the clinic. Based on an individual's genome, the test identifies the best medicine for a particular disease, avoids those that would cause an adverse reaction, and guides dosing levels. The test, according to Prenetics, avoids the "trial and error" method of prescribing medicines. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital